Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
etoposide (vepesid) (1 trial)
gemcitabine (gemzar) (1 trial)
Pancreatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)